Jun 12, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, welcome to the Mersana Therapeutics Annual Meeting of Stockholders. I will now turn the program over to Chairman of the Board of Directors, David Mott. Dave, you may begin.
David M. Mott - Mersana Therapeutics, Inc. - Independent Chairman
Good morning, everyone. It's 9:00 a.m. I'm David Mott, Chairman of the Board of Mersana Therapeutics, and it's a pleasure to welcome you to Mersana's 2020 Annual Meeting of Stockholders, which I now call to order and for which I will be acting as Chairperson.
I'd now like to introduce Anna Protopapas, Mersana's Chief Executive Officer, who will proceed with the business of the meeting. Anna?
Anna Protopapas - Mersana Therapeutics, Inc. - President, CEO & Director
Thank you, Dave, and thank you all for attending today's meeting. In keeping with all that Mersana has done in the past several months to continue operations in the midst of the COVID pandemic, we are hosting our annual meeting virtually this year.
As is our custom, we will
Mersana Therapeutics Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot